Replies to post #386821 on Amarin Corp Plc (AMRN)

[ziploc_1]

The leading cardiologists on the FDA panel as well as Dr. Bhatt, did NOT think another event study without using MO as a placebo was necessary to show that Vascepa was safe and effective at reducing CVD.

[Whalatane]

Dr Nissen ...thx for posting here on IHUB :--)

According to you ...nothing but a redo of the REDUCE -IT trial will suffice .
Which of course will almost never happen .

The RESPECT EPA data and any long term CV data they collect in MITIGATE.... is simply a waste of time and $.....according to U .

Kiwi